Q. Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?
A. Dabrafenib
B. Dabrafenib plus vemurafenib
C. Dabrafenib plus trametinib
D. Dabrafenib plus ipilimumab
Answer: Dabrafenib plus trametinib
A. Dabrafenib
B. Dabrafenib plus vemurafenib
C. Dabrafenib plus trametinib
D. Dabrafenib plus ipilimumab
Answer: Dabrafenib plus trametinib
Government Schemes Mock Test | Start Test! |
Political Science Mock Test – 42 | Start Test |
History Test – 190 | Start Test |
Quantitative Aptitude Test | Start Test! | Data Interpretation - Mock Test | Start Test! |
General Awareness - Mock Test | Start Test! |
Reasoning Ability - Mock Test | Start Test! |